Debomoy K. Lahiri

25.3k total citations · 3 hit papers
319 papers, 20.7k citations indexed

About

Debomoy K. Lahiri is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Debomoy K. Lahiri has authored 319 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Physiology, 120 papers in Molecular Biology and 73 papers in Pharmacology. Recurrent topics in Debomoy K. Lahiri's work include Alzheimer's disease research and treatments (158 papers), Cholinesterase and Neurodegenerative Diseases (68 papers) and Computational Drug Discovery Methods (35 papers). Debomoy K. Lahiri is often cited by papers focused on Alzheimer's disease research and treatments (158 papers), Cholinesterase and Neurodegenerative Diseases (68 papers) and Computational Drug Discovery Methods (35 papers). Debomoy K. Lahiri collaborates with scholars based in United States, India and Canada. Debomoy K. Lahiri's co-authors include John I. Numberger, Nigel H. Greig, Bryan Maloney, Kumar Sambamurti, Balmiki Ray, Jack T. Rogers, Justin M. Long, Martin R. Farlow, Harold W. Holloway and Nasser H. Zawia and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Debomoy K. Lahiri

311 papers receiving 20.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

1991 2.0k citations Debomoy K. Lahiri et al. profile →
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

2005 645 citations Nigel H. Greig, Harold W. Holloway et al. Proceedings of the National Academy of Sciences profile →
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

2009 502 citations Yazhou Li, Mark S. Kindy et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debomoy K. Lahiri United States	78	7.5k	7.1k	4.5k	3.0k	2.3k	319	20.7k
Sam Gandy United States	74	13.2k 1.8×	8.1k 1.2×	3.3k 0.7×	3.7k 1.2×	1.6k 0.7×	292	21.5k
Huaxi Xu United States	75	11.9k 1.6×	8.3k 1.2×	2.9k 0.6×	3.5k 1.2×	1.3k 0.5×	195	21.4k
Martin R. Farlow United States	79	12.5k 1.7×	8.0k 1.1×	6.9k 1.5×	3.2k 1.1×	2.8k 1.2×	375	26.9k
Thomas Wısnıewskı United States	76	11.7k 1.5×	8.8k 1.2×	2.3k 0.5×	3.4k 1.1×	1.7k 0.8×	389	20.5k
Craig Atwood United States	54	9.2k 1.2×	4.8k 0.7×	2.4k 0.5×	1.5k 0.5×	1.3k 0.6×	146	15.9k
D. E. Schmechel United States	28	13.2k 1.7×	8.2k 1.2×	2.3k 0.5×	3.6k 1.2×	1.5k 0.6×	39	21.1k
Bruce A. Yankner United States	57	12.1k 1.6×	13.5k 1.9×	3.2k 0.7×	5.6k 1.9×	1.3k 0.6×	79	26.4k
Warren J. Strittmatter United States	53	14.8k 2.0×	10.7k 1.5×	2.6k 0.6×	5.2k 1.8×	1.6k 0.7×	107	25.3k
Xiongwei Zhu United States	94	14.5k 1.9×	13.5k 1.9×	4.2k 0.9×	4.4k 1.5×	1.2k 0.5×	345	28.6k
D. Allan Butterfield United States	93	13.4k 1.8×	12.4k 1.7×	4.0k 0.9×	3.4k 1.2×	935 0.4×	286	27.8k

Countries citing papers authored by Debomoy K. Lahiri

Since Specialization

Citations

This map shows the geographic impact of Debomoy K. Lahiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debomoy K. Lahiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debomoy K. Lahiri more than expected).

Fields of papers citing papers by Debomoy K. Lahiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debomoy K. Lahiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debomoy K. Lahiri. The network helps show where Debomoy K. Lahiri may publish in the future.

Co-authorship network of co-authors of Debomoy K. Lahiri

This figure shows the co-authorship network connecting the top 25 collaborators of Debomoy K. Lahiri. A scholar is included among the top collaborators of Debomoy K. Lahiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debomoy K. Lahiri. Debomoy K. Lahiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ruizhi, Bryan Maloney, John S. Beck, Scott Counts, & Debomoy K. Lahiri. (2025). MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease. Alzheimer s & Dementia. 21(8). e70399–e70399.

Sokol, Deborah K. & Debomoy K. Lahiri. (2024). Alzheimer’s drugs, APPlication for Down syndrome?. Ageing Research Reviews. 96. 102281–102281. 3 indexed citations

Nguyen, Tyler, Brittany Davis, Debomoy K. Lahiri, et al.. (2023). Propranolol treatment during repetitive mild traumatic brain injuries induces transcriptomic changes in the bone marrow of mice. Frontiers in Neuroscience. 17. 1219941–1219941. 3 indexed citations

Sokol, Deborah K. & Debomoy K. Lahiri. (2023). APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder. Frontiers in Molecular Neuroscience. 16. 1201744–1201744. 4 indexed citations

Schmued, Larry, et al.. (2023). Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 97(1). 239–247. 1 indexed citations

Niculescu, Alexander B., H Le-Niculescu, K. Roseberry, et al.. (2019). Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. PMC. 1 indexed citations

Long, Justin M., Bryan Maloney, Jack T. Rogers, & Debomoy K. Lahiri. (2018). Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease. Molecular Psychiatry. 24(3). 345–363. 120 indexed citations

Doeppner, Thorsten R., Desiree Willkommen, Catherine M. Cahill, et al.. (2018). Manganese causes neurotoxic iron accumulation via translational repression of Amyloid Precursor Protein (APP) and H-Ferritin. PMC. 2 indexed citations

Kim, Eunhee, Moon‐Sook Woo, Luye Qin, et al.. (2015). Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke. PMC. 1 indexed citations

10.

Balaraman, Yokesh, Debomoy K. Lahiri, & John I. Nürnberger. (2015). Variants in Ion Channel Genes Link Phenotypic Features of Bipolar Illness to Specific Neurobiological Process Domains. PMC. 6 indexed citations

11.

Greig, Nigel H., David Tweedie, Lital Rachmany, et al.. (2014). Incretin mimetics as pharmacological tools to elucidate and as a new drug strategy to treat traumatic brain injury. PMC. 25 indexed citations

12.

Ray, Balmiki, Savita Bisht, Amarnath Maitra, Anirban Maitra, & Debomoy K. Lahiri. (2011). Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurc™) in the Neuronal Cell Culture and Animal Model: Implications for Alzheimer's disease. Journal of Alzheimer s Disease. 23(1). 61–77. 142 indexed citations

13.

Maloney, Bryan, Yuan‐Wen Ge, Ronald C. Petersen, et al.. (2010). Functional Characterization of Three Single-Nucleotide Polymorphisms Present in the Human APOε Promoter Sequence: Differential Effects in Neuronal Cells and on DNA–Protein Interactions. UCL Discovery (University College London). 2 indexed citations

14.

Patel, Sagar D., H Le-Niculescu, Daphne Koller, et al.. (2010). Coming to grips with complex disorders: Genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(4). 850–877. 56 indexed citations

15.

Li, Yazhou, Mark S. Kindy, Brandon K. Harvey, et al.. (2009). GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proceedings of the National Academy of Sciences. 106(4). 1285–1290. 502 indexed citations breakdown →

16.

Maloney, Bryan, Yuan-Wen Ge, Nigel H. Greig, & Debomoy K. Lahiri. (2006). Characterization of the Human β-Secretase 2 (BACE2) 5\'-Flanking Region: Identification of a 268-bp Region as the Basal BACE2 Promoter. Journal of Molecular Neuroscience. 29(1). 81–100. 13 indexed citations

17.

Sambamurti, Kumar, Anitha Suram, Chitra Venugopal, et al.. (2006). A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis. Current Alzheimer Research. 3(1). 81–90. 49 indexed citations

18.

Kotwal, Girish J. & Debomoy K. Lahiri. (2005). Natural products and molecular therapy. New York Academy of Sciences eBooks. 6 indexed citations

19.

Campbell, Arezoo, et al.. (2004). Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. Journal of Neuroscience Research. 75(4). 565–572. 149 indexed citations

20.

Lahiri, Debomoy K.. (2004). Protective strategies for neurodegenerative diseases. New York Academy of Sciences eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact